OptimizeRx (OPRX) To Report Q2 Earnings: What's In Store?
Zacks Investment Research | Aug 01, 2019 11:20PM ET
OptimizeRx Corp. (NASDAQ:OPRX) is scheduled to report second-quarter 2019 results on Aug 7.
In the last reported quarter, the company came up with a positive surprise of 100%. In fact, the company’s earnings history is impressive, having trumped the Zacks Consensus Estimate in each of the trailing four quarters, the average being 133.33%.
Meanwhile, revenues of $5 million in the same period matched the Zacks Consensus Estimate. The same, however, improved 27% from the year-ago quarter.
The Zacks Consensus Estimate for second-quarter 2019 revenues is pegged at $6.8 million, indicating a nearly 32.9% increase from the year-ago reported figure.
The Zacks Consensus Estimate for earnings stands at 8 cents, suggesting a 300% surge from the number reported in the prior-year quarter.
Let’s see how things are shaping up for the upcoming announcement.
Factors to Consider
OptimizeRx’s performance in the upcoming quarterly results is likely to be driven by its diversified revenue streams, broader provider reach, scalable technology and strong operational efficiency.
The company’s focus on expanding its channel partners is also likely to expand transaction volume this earnings season. Increased sales of core financial and brand messaging products are expected to boost the quarterly results.
Moreover, the CareSpeak buyout is a positive. Additionally, expanded platform integrations with leading electronic health record systems, such as Epic and Cerner (NASDAQ:CERN) in the last reported quarter make us optimistic.
Further, a favorable product mix shift is expected to boost gross margins in the soon-to-be-reported quarter. However, expenses related to the integration of CareSpeak are an overhang.
OptimizeRx Corp. Price and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.